Compare KeyCorp (KEY) vs Sana Biotechnology Inc (SANA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
KeyCorp vs Sana Biotechnology Inc — how do they compare? KeyCorp trades at $23.55 (market cap $25.17B), while Sana Biotechnology Inc trades at $3.17 (market cap $873.84M). The key difference: KeyCorp is far larger — about 28.8× Sana Biotechnology Inc's market cap, and KeyCorp pays a 3.52% dividend while Sana Biotechnology Inc pays none. Which is the better fit depends on your goals.
| KEY | SANA | |
|---|---|---|
Market Cap | $25.17B | $873.84M |
Sector | Financials | Health |
52-Week High | $23.99 | $5.92 |
52-Week Low | $16.78 | $2.68 |
Dividend Yield | 3.52% | — |
Enterprise Value | — | $848.03M |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About KeyCorp
With assets of over $170 billion, Ohio-based KeyCorp's bank footprint spans 16 states, but it is predominantly concentrated in its two largest markets: Ohio and New York. KeyCorp is primarily focused on serving middle-market commercial clients through a hybrid community/corporate bank model.
Read more on KEY →About Sana Biotechnology Inc
Sana Biotechnology Inc. is a clinical-stage biopharmaceutical company focused on creating and delivering engineered cells as medicines for patients. The company is developing cell therapies for various diseases, including oncology, diabetes, and central nervous system disorders. Sana's core strategy is built around two key technological platforms: in vivo gene delivery to repair cells inside the body and ex vivo cell engineering for therapeutic use.
Read more on SANA →
